Skip to main content
. 2020 Mar 15;12(3):695. doi: 10.3390/cancers12030695
AUC area under the curve
BCBM breast cancer brain metastasis
CA19-9 cancer antigen 19-9
CEA carcinoembryonic antigen
CI confidence interval
CTC circulating tumor cell
CTM circulating tumor microembolies
DC disease control
CA19-9 cancer antigen 19-9
CEA carcinoembryonic antigen
CI confidence interval
CTC circulating tumor cell
CTM circulating tumor microembolies
DC disease control
DFS disease-free survival
ECM extracellular matrix
EMT epithelial to mesenchymal transition
EpCAM epithelial cell adhesion molecule
GC gastric cancer
IHC immunohistochemistry
HR hazard ratio
MET mesenchymal to epithelial cell transition
MHC major histocompatibility complex
MP1-MMP membrane type 1 matrix metalloproteinase
OS overall survival
ROC receiver operating characteristic
WBC white blood cell